Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? No, It's Time to Move On! Diabetes Care 2015;38: 170-175

  • Dennis Schrijnders*
  • , Sebastiaan T. Houweling
  • , Gijs W. D. Landman
  • *Corresponding author for this work

    Research output: Contribution to journalEditorialAcademicpeer-review

    Original languageEnglish
    Pages (from-to)E94-E94
    Number of pages1
    JournalDiabetes Care
    Volume38
    Issue number6
    DOIs
    Publication statusPublished - Jun-2015

    Cite this